Australia markets closed

Biomark Diagnostics Inc. (20B.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1660-0.0010 (-0.60%)
As of 08:16AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
163.161
153.492
43.933
0
Operating expenses
Research development
704.293
545.841
497.773
118.432
Selling general and administrative
721.415
958.959
564.508
868.527
Total operating expenses
1,802
1,886
1,447
1,083
Operating income or loss
-1,638
-1,732
-1,403
-1,083
Interest expense
96.95
110.232
49.683
4.138
Total other income/expenses net
-
-
-1.114
-7.467
Income before tax
-1,538
-1,842
-1,454
-1,094
Income from continuing operations
-1,538
-1,842
-1,454
-1,094
Net income
-1,538
-1,842
-1,454
-1,094
Net income available to common shareholders
-1,538
-1,842
-1,454
-1,094
Basic EPS
-0.03
-0.02
-0.02
-0.02
Diluted EPS
-0.03
-0.02
-0.02
-0.02
Basic average shares
88,264
82,778
77,929
73,305
Diluted average shares
88,264
82,778
77,929
73,305